The grey market is signalling strong investor interest in the Molbio Diagnostics IPO, with the latest grey market premium (GMP) standing at around ₹138 per share.
The grey market is signalling strong investor interest in the Molbio Diagnostics IPO, with the latest grey market premium (GMP) standing at around ₹138 per share.
<iframe src="https://hindustansphere.com/embed/cluster/d2b78c1d153050a37de01fb2c703d1b2a4015aa1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Molbio Diagnostics IPO Day 3: Issue subscribed 4.39 times so far. Here's GMP, size, & other details - Apply or not?"></iframe>
